𝔖 Bobbio Scriptorium
✦   LIBER   ✦

568 Efficacy and safety of the treatment with peginterferon alpha-2a (PEGASYS®) plus ribavirin in patients with chronic hepatitis C genotype 4: Interim results

✍ Scribed by M. Diago; J. Boadas; R. Planasi; R. Solá; J.A. del Olmo; J. Crespo; J.C. Erdozaid; M.D. Antón

Book ID
117374845
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
134 KB
Volume
44
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of peginterferon alp
Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C
✍ Richard Njouom; Michèle Tagni Sartre; Isabelle Timba; Eric Nerrienet; Patrice Tc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract Data were examined from a day‐to‐day clinical practice in Yaounde, Cameroon to evaluate the efficacy and safety of peginterferon alfa‐2a and ribavirin in treatment‐naive Cameroonian patients with chronic hepatitis C. Ninety adults with chronic hepatitis C (mean age, 53 ± 8 years; 79% ma